Potential New Agents for the Management of Hyperkalemia.

about

Patiromer: A Review in Hyperkalaemia.Safety of potassium-bearing citrate in patients with renal transplantation: A case report.

P2860

Q38886795-B908EA4E-358E-4A8E-B2A8-ECDD4AA54A7A Q47106753-3561CF15-ED61-4360-B639-3B2E341F5499

P2860

Potential New Agents for the Management of Hyperkalemia.

Item

http://www.wikidata.org/entity/Q38544101

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Potential New Agents for the Management of Hyperkalemia.

@en

type

Item

label

Potential New Agents for the Management of Hyperkalemia.

@en

prefLabel

Potential New Agents for the Management of Hyperkalemia.

@en

P1476

Potential New Agents for the Management of Hyperkalemia.

@en

P2093

David K Packham

http://www.w3.org/2001/XMLSchema#string

Mikhail Kosiborod

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Angiotensin receptor blockers for heart failure

Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Characterization of structure and function of ZS-9, a K+ selective ion trap

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.

P2888

s40256-015-0130-7

P304

19-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-015-0130-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030736697

http://www.w3.org/2001/XMLSchema#string

P698

26156040

http://www.w3.org/2001/XMLSchema#string

Potential New Agents for the Management of Hyperkalemia.

about

P2860

P2860

Potential New Agents for the Management of Hyperkalemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698